We are live on ! Find out more
CC

Capital Counsel Portfolio holdings

AUM $2.35B
1-Year Est. Return 21.34%
This Fund
S&P 500
This Quarter Est. Return
+9.55%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$2.13B
AUM Growth
+$351M
Cap. Flow
+$195M
Cap. Flow %
9.15%
Top 10 Hldgs %
57.71%
Holding
137
New
6
Increased
26
Reduced
40
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 24.91%
2 Industrials 23.8%
3 Financials 11.71%
4 Technology 9.88%
5 Consumer Staples 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBCT
126
DELISTED
People's United Financial Inc
PBCT
$197K 0.01%
13,000
VLY icon
127
Valley National Bancorp
VLY
$7.9B
$136K 0.01%
14,000
+3,000
+27% +$29.1K
CCEP icon
128
Coca-Cola Europacific Partners
CCEP
$48.3B
-41,975
Closed -$1.86M
COP icon
129
ConocoPhillips
COP
$147B
-2,845
Closed -$218K
FAST icon
130
Fastenal
FAST
$54.7B
-358,264
Closed -$4.02M
GOOG icon
131
Alphabet (Google) Class C
GOOG
$4.36T
-14,961
Closed -$434K
HRI icon
132
Herc Holdings
HRI
$5.02B
-4,300
Closed -$328K
PM icon
133
Philip Morris
PM
$297B
-2,446
Closed -$204K
VTLE
134
DELISTED
Vital Energy
VTLE
-478
Closed -$214K

Similar funds

Capital Counsel's Q4 2014 Portfolio in Review

As of Q4 2014, Capital Counsel held 137 positions worth $2.13B, up 20% from $1.78B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Capital Counsel deployed $195M of net new capital in Q4 2014, opening 6 new positions and adding to 26 existing holdings. Its largest new stake was CDK Global, Inc.: 1,701,952 shares worth $69.4M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Core Laboratories, an estimated $39.2M trimmed.

  • Capital Counsel's largest Q4 2014 buy was CDK Global, Inc.: 1,701,952 shares worth $69.4M.
  • Capital Counsel added most to Ecolab in Q4 2014, an estimated $33.8M increase.
  • Capital Counsel's biggest Q4 2014 reduction was Core Laboratories, cutting an estimated $39.2M.
  • Capital Counsel fully exited Fastenal in Q4 2014, selling an estimated $4.02M.
  • Capital Counsel's ten largest holdings make up 58% of its $2.13B portfolio in Q4 2014.
  • Capital Counsel opened 6 new positions and closed 7 in Q4 2014.
  • Capital Counsel's portfolio value rose 20% quarter-over-quarter to $2.13B.

Based on Capital Counsel's 13F filing for Q4 2014, filed 11 Feb 2015.